Financial Performance - Operating revenue decreased by 15.19% to CNY 1,048,731,630.47 year-on-year[6] - Net profit attributable to shareholders decreased by 130.91% to a loss of CNY 28,867,832.57 compared to the same period last year[6] - Basic and diluted earnings per share were both CNY -0.03, a decrease of 130.00% compared to the previous year[6] - Operating profit for Q1 2015 was a loss of CNY 29,559,284.09, compared to a profit of CNY 107,902,950.24 in the previous year[23] - The company reported a net loss of CNY 27,093,162.61 for the quarter, compared to a profit of CNY 105,638,723.63 in the same quarter last year[23] - The company's net profit for Q1 2015 was -31,902,267.23 RMB, compared to a profit of 93,145,754.33 RMB in the same period last year, indicating a significant decline[24] - Total comprehensive income for the period was 63,108,950.23 RMB, down from 88,723,633.11 RMB in the previous year[24] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 89,732,995.55, worsening by 499.01% year-on-year[6] - The company reported a net cash outflow from operating activities of -89,732,995.55 RMB, worsening from -14,980,136.56 RMB in the previous year[27] - Operating cash flow for Q1 2015 was negative at -16,710,552.37 RMB, a significant decline from 113,077,534.22 RMB in the same period last year[29] - Total cash inflow from operating activities decreased to 666,642,151.26 RMB, down 15.7% from 790,858,200.35 RMB year-over-year[29] - Cash outflow from operating activities increased to 683,352,703.63 RMB, compared to 677,780,666.13 RMB in Q1 2014[30] - Cash inflow from financing activities was 250,000,000.00 RMB, with a net cash flow of 246,590,763.90 RMB after outflows[30] Assets and Liabilities - Total assets increased by 4.17% to CNY 8,197,702,498.57 compared to the end of the previous year[6] - Total liabilities reached CNY 1,180,011,436.45, significantly up from CNY 570,197,468.28 at the start of the year[21] - Cash and cash equivalents increased to CNY 941,842,950.17 from CNY 854,863,978.74 at the beginning of the year[20] - Inventory levels rose to CNY 553,038,688.09, compared to CNY 475,800,965.62 at the start of the year, indicating a 16.2% increase[20] - Non-current assets totaled CNY 4,724,271,399.08, up from CNY 3,224,506,684.91 at the beginning of the year[20] Shareholder Information - The total number of shareholders reached 69,057 at the end of the reporting period[10] - The largest shareholder, New Changxing Investment Development Co., Ltd., holds 22.14% of the shares[10] Financial Ratios and Metrics - The weighted average return on equity dropped by 1.875 percentage points to -0.439%[6] - Financial expenses increased by 211.40% to ¥13,442,642.68 due to increased bank borrowings[12] - Asset impairment losses rose by 507.21% to ¥28,450,716.78, attributed to an increase in accounts receivable[12] - Short-term borrowings increased by 250.00% to ¥350,000,000.00, reflecting increased bank financing during the reporting period[12] Investment and Other Income - Investment income surged by 16,893.45% to ¥60,925,574.67, resulting from the sale of part of available-for-sale equity instruments[13] - Other comprehensive income increased by 2,257.41% to ¥95,403,153.75, driven by changes in the fair value of available-for-sale financial assets[13] - Cash received from tax refunds decreased by 41.24% to ¥40,383,292.32 due to reduced export tax rebates[13] - Cash received from operating activities rose by 71.84% to ¥30,315,398.64, attributed to increased operational transactions[13]
浙江医药(600216) - 2015 Q1 - 季度财报